Santen Pharmaceutical Co., Ltd. financial statements, including revenue, expenses, profit, and loss

The total revenue of SNPHY for the last quarter is 480.00 M USD, and it's 0.04% higher compared to the previous quarter. The net income of Q2 24 is 54.54 M USD.